What's Happening?
AMR Clinical, a prominent multi-site research company, has announced the acquisition of ClinOhio Research Services, a Columbus, Ohio-based multi-therapeutic research site. Founded in 2017, ClinOhio is known for its high-quality clinical research in Dermatology,
Women's Health, and Gastroenterology. This acquisition is set to enhance AMR's geographic presence and strengthen its capabilities in these therapeutic areas. Kari L. Delahunty, CEO of AMR Clinical, emphasized that ClinOhio's experienced investigators and strong patient relationships align with AMR's commitment to high-quality research. The integration will leverage AMR's operational infrastructure and sponsor relationships to expand trial complexity and enhance execution consistency.
Why It's Important?
The acquisition of ClinOhio by AMR Clinical is significant as it expands AMR's footprint in the clinical research industry, particularly in the Columbus market. This move is expected to provide greater access to patient populations and support more complex clinical trials. For the healthcare industry, this acquisition could lead to advancements in medical research and improved patient outcomes, particularly in the fields of Dermatology, Women's Health, and Gastroenterology. The integration of ClinOhio's capabilities with AMR's infrastructure is likely to attract more sponsors and increase the availability of clinical trials, benefiting both the research community and patients.
What's Next?
Following the acquisition, AMR Clinical plans to integrate ClinOhio's operations with its existing infrastructure. This will involve leveraging AMR's centralized support functions and data capabilities to drive growth and expand the complexity of clinical trials conducted at the site. The focus will be on maintaining high standards of research while expanding into additional therapeutic areas. Stakeholders, including sponsors and healthcare providers, are expected to closely monitor the integration process and its impact on clinical trial availability and execution.
